Curium to buy Lantheus for up to $114.50/share in cash (LNTH:NASDAQ)
· seekingalpha.com
Curium to acquire Lantheus (LNTH) for up to $114.50/share in cash + CVRs—38% premium.
Curium announced a deal to acquire all outstanding shares of radiopharmaceutical-focused company Lantheus Holdings (LNTH) for up to $114.50/share in cash.
Unde...